Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.3.13NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCUNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.27.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KB.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.51.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDD.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.526 (Iota)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.2 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.621 (Mu)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.9.2 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.34 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.47 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.17 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.126 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.48 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.116.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.52 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.13 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.35 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.122 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.7 (Alpha)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.120.1 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GE.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.93NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.2.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.4.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5.1.18NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GM.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.13.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GV.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.2.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.26NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GJ.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.14.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.3.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DY.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used